Xian Gmei Li
Corporate Secretary bij MICROPORT CARDIOFLOW MEDTECH CORPORATION
Profiel
Xian Gmei Li is currently a Joint Secretary at MicroPort CardioFlow Medtech Corp.
She previously worked as a Senior Manager at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and as a Manager-Investor Relations at Sinopec Shanghai Petrochemical Co., Ltd.
Ms. Li received an undergraduate degree from Zhengzhou University in 2002.
Actieve functies van Xian Gmei Li
| Bedrijven | Functie | Begin |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Corporate Secretary | 27-10-2020 |
Eerdere bekende functies van Xian Gmei Li
| Bedrijven | Functie | Einde |
|---|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Corporate Officer/Principal | 01-01-2020 |
| SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED | Investor Relations Contact | 01-12-2014 |
Opleiding van Xian Gmei Li
| Zhengzhou University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED | Energy Minerals |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
